Taken together, AS inhibits proliferation and induces apoptosis through ER stress‐activated PERK/eIF2α/CHOP pathway in ESCC, which indicates AS represents a promising candidate for ESCC treatment. This evidence concerns the gene DDIT3 and esophageal squamous cell carcinoma.